The following is a summary of “Dual seropositive nonerosive lupus arthritis: rhupus or not?” published in the February 2025 ...

Explore how tumor necrosis factor inhibitors (TNFis) may reduce cardiovascular risks in patients with inflammatory arthritis, ...

In a ground-breaking revelation, Dr Tamiko Katsumoto, a renowned rheumatology and immunology expert from Stanford University, ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Frailty is increasingly being viewed as an emerging risk factor for poor outcomes among patients with autoimmune or rheumatic ...

Arthritis is a common condition that affects millions of people worldwide. Two of the most prevalent forms are osteoarthritis (OA) and rheumatoid arthritis (RA).

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Tofacitinib and TNF inhibitors demonstrated similar efficacy for managing RA at 12 months, with minor differences noted across tofacitinib treatment lines.

Janus kinase (JAK) inhibitors look to be a good treatment option for the newly recognized, rare autoimmune disease known as ...